Back to search results

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE3

Conditions

B-cell Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Kevin Curran, MD) · 1-833-MSK-KIDS
    Contact: Study coordinator (Jaap Jan Boelens, MD,PhD) · 1-833-MSK-KIDS
    Contact: Principal Investigator (Kevin Curran, MD)

  • Cincinnati Children's Hospital Medical Center (Data Collection Only), Cincinnati, Ohio, United States

    Contact: Study coordinator (Christine Phillips, MD) · 513-636-4266

  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Regina Myers, MD) · 267-426-0762

  • Baylor College Medical Center (Data Collection Only), Houston, Texas, United States

    Contact: Study coordinator (Rayne Rouce, MD) · rouce@bcm.edu

  • Texas Children's Hospital (Data Collection), Houston, Texas, United States

    Contact: Study coordinator (Rayne Rouce, M.D., B.S.) · 832-822-4242
Study leads

  • Kevin Curran, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)